Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy
Crossref DOI link: https://doi.org/10.21037/tlcr-20-148
Published Online: 2020-08
Published Print: 2020-08
Update policy: https://doi.org/10.21037/ame_crossmark_policy
Chae, Young Kwang
Kim, Won Bin
Davis, Andrew A.
Park, Lee Chun
Anker, Jonathan F.
Simon, Nicholas I.
Rhee, Kyunghoon
Song, Junho
Cho, Anderson
Chang, Sangmin
Ko, Taeyeong
Oh, Michael
Bhave, Manali
Viveiros, Pedro